The present invention generally relates to inhibitors of isoprenylcysteine carboxyl methyltransferase (Icmt), in particularly to compounds that inhibit Icmt activity and pharmaceutical compositions thereof. The invention also relates to methods of disease treatment using the same.
本发明通常涉及
异戊二烯基半胱
氨酸羧
甲基转移酶(Icmt)的
抑制剂,特别是抑制Icmt活性的化合物及其药物组合物。本发明还涉及使用这些
抑制剂进行疾病治疗的方法。